-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation